Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial
Sabina Chiaretti(Sapienza University of Rome), Renato Bassan(Pittini Group (Italy)), Anna Candoni(University of Udine), Mariangela Di Trani(Sapienza University of Rome), Robin Foà(Sapienza University of Rome), Orietta Spinelli(Ospedale Papa Giovanni XXIII), Paola Fazi(Fondazione Gimema Onlus), Monica Messina(Fondazione Gimema Onlus), Erika Borlenghi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alfonso Piciocchi(Fondazione Gimema Onlus), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Felicetto Ferrara(San Antonio College), Alessandra Santoro(Ospedale Vincenzo Cervello), Monia Lunghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Fabrizio Pane(Federico II University Hospital), Patrizia Zappasodi(Policlinico San Matteo Fondazione), Irene Della Starza(Associazione Italiana Ematologia Oncologia Pediatrica), Catello Califano(Presidio Ospedaliero), Matteo Piccini(Azienda Ospedaliero-Universitaria Careggi), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Elisa Mauro(Ferrarotto Hospital), Anna Maria Mianulli(Azienda Unità Sanitaria Locale Della Romagna), Maria Stefania De Propris(Sapienza University of Rome), Albana Liço(Ospedale San Bortolo), Valentina Arena(Fondazione Gimema Onlus), Loredana Elia(Sapienza University of Rome), Monica Bocchia(University of Siena)
Cited by 28
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644